Does PEMBROLIZUMAB Cause Type 2 diabetes mellitus? 113 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Type 2 diabetes mellitus have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.1% of all adverse event reports for PEMBROLIZUMAB.
113
Reports of Type 2 diabetes mellitus with PEMBROLIZUMAB
0.1%
of all PEMBROLIZUMAB reports
4
Deaths
60
Hospitalizations
How Dangerous Is Type 2 diabetes mellitus From PEMBROLIZUMAB?
Of the 113 reports, 4 (3.5%) resulted in death, 60 (53.1%) required hospitalization, and 6 (5.3%) were considered life-threatening.
Is Type 2 diabetes mellitus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Type 2 diabetes mellitus?
ATORVASTATIN (7,556)
ADALIMUMAB (3,516)
PREDNISONE (3,484)
METHOTREXATE (3,465)
RITUXIMAB (3,318)
TOCILIZUMAB (3,145)
ABATACEPT (3,074)
LEFLUNOMIDE (3,033)
ALENDRONATE (3,002)
DICLOFENAC (2,974)
Which PEMBROLIZUMAB Alternatives Have Lower Type 2 diabetes mellitus Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G